Category
21 stories · page 2 of 2
Skin
Layered toners, essences, serums and creams are visible again. Humectants plus occlusion may comfort dry skin, but a longer routine can also increase irritant and allergen exposure. Meaningful skin results depend on the complete formula, frequency, tolerance and finished-product data—not one fashionable ingredient.
Skin
Ectoin is moving into barrier, redness and anti-pollution formulas. The biology is interesting, yet concentrations, vehicles and finished-product trials differ widely. Meaningful skin results depend on the complete formula, frequency, tolerance and finished-product data—not one fashionable ingredient.
Skin
Three primary company disclosures point to very different kinds of beauty momentum in 2026. LCY compares the periods, metrics and category signals without turning unlike numbers into a false ranking.
Skin
Shiseido’s 21 August 2026 announcement of a new Elixir high-moisture lotion is a useful product-intelligence signal, but it is not independent proof of superior skin outcomes. LifeCareYou separates what the company has documented about the launch from what still needs finished-product, comparative and post-market evidence. The timely signal is the claim language: the release defines “mask-level” as moisturizing performance equivalent to an Elixir sheet mask, then separately states a...
Technology
A new color-science collaboration targets better complexion matching. The research question is important—but the announcement is not yet a validation result.
Skin
Why an ingredient name alone cannot prove a skincare result, and how LCY compares concentration, formulation, finished-product evidence, safety and claim scope.
Skin
A primary-source read of the 2026 U.S. rollout—and why retail scale is a market signal, not proof that every product claim works.
Skin
The LCY method for deciding when a beauty launch is a single announcement, a repeated market signal or a wider trend—and what the evidence cannot prove.
Skin
How LifeCareYou evaluates cosmetic launches across markets without confusing novelty, brand claims, retailer visibility and scientific support.
